1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Fahrner, R.L. Dieckmann, T. Harwig, S.S.L. Lehrer, R.I. Eisenberg, D. Feigon, J. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking H2 N 16.023 AMINO GROUP non-polymer C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking UK Chem.Biol. CBOLE2 2050 1074-5521 3 543 550 10.1016/S1074-5521(96)90145-3 8807886 Solution structure of protegrin-1, a broad-spectrum antimicrobial peptide from porcine leukocytes. 1996 10.2210/pdb1pg1/pdb pdb_00001pg1 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 2164.679 PROTEGRIN-1 1 nat polymer no yes RGGRLCYCRRRFCVCVGR(NH2) RGGRLCYCRRRFCVCVGRX A polypeptide(L) n n n n n n n n n n n n n n n n n n n pig Sus sample 9823 Sus scrofa LEUKOCYTE database_2 pdbx_database_status pdbx_struct_assembly pdbx_struct_oper_list struct_conn struct_site repository Initial release Version format compliance Version format compliance Database references Derived calculations Other 1 0 1998-05-27 1 1 2008-03-24 1 2 2011-07-13 1 3 2022-02-23 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_database_status.process_site _struct_conn.pdbx_leaving_atom_flag _struct_conn.ptnr1_auth_comp_id _struct_conn.ptnr1_auth_seq_id _struct_conn.ptnr1_label_atom_id _struct_conn.ptnr1_label_comp_id _struct_conn.ptnr1_label_seq_id _struct_conn.ptnr2_auth_comp_id _struct_conn.ptnr2_auth_seq_id _struct_conn.ptnr2_label_atom_id _struct_conn.ptnr2_label_comp_id _struct_conn.ptnr2_label_seq_id _struct_site.pdbx_auth_asym_id _struct_site.pdbx_auth_comp_id _struct_site.pdbx_auth_seq_id Y BNL 1998-03-20 REL LEAST RESTRAINT VIOLATION, LEAST GEOMETRY VIOLATION 100 20 NOESY TOCSY DQF-COSY 6.5 293 K REFINEMENT DETAILS CAN BE FOUND IN THE JOURNAL CITATION ABOVE. DISTANCE GEOMETRY SIMULATED ANNEALING BRUNGER refinement X-PLOR 3.1 structure solution AURELIA structure solution X-PLOR 3.1 500 Bruker AMX500 ARG 1 n 1 ARG 1 A GLY 2 n 2 GLY 2 A GLY 3 n 3 GLY 3 A ARG 4 n 4 ARG 4 A LEU 5 n 5 LEU 5 A CYS 6 n 6 CYS 6 A TYR 7 n 7 TYR 7 A CYS 8 n 8 CYS 8 A ARG 9 n 9 ARG 9 A ARG 10 n 10 ARG 10 A ARG 11 n 11 ARG 11 A PHE 12 n 12 PHE 12 A CYS 13 n 13 CYS 13 A VAL 14 n 14 VAL 14 A CYS 15 n 15 CYS 15 A VAL 16 n 16 VAL 16 A GLY 17 n 17 GLY 17 A ARG 18 n 18 ARG 18 A NH2 19 n 19 NH2 19 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A O LEU 5 A O LEU 5 A N VAL 16 A N VAL 16 1 A A O H ARG ARG 9 11 1.55 1 A A HH12 O ARG ARG 1 4 1.59 1 A A HH11 O ARG GLY 1 2 1.60 2 A A HH22 O ARG GLY 1 17 1.44 2 A A HE O ARG GLY 1 2 1.46 2 A A O H TYR VAL 7 14 1.56 3 A A HE O ARG GLY 1 2 1.42 3 A A HH22 O ARG GLY 1 17 1.46 3 A A HH21 O ARG GLY 1 3 1.47 3 A A O H TYR VAL 7 14 1.48 3 A A H O LEU VAL 5 16 1.56 3 A A O H ARG ARG 9 11 1.60 4 A A HH21 O ARG GLY 1 3 1.39 4 A A HE O ARG VAL 4 16 1.50 4 A A HE O ARG ARG 1 4 1.52 4 A A O H ARG ARG 9 11 1.53 4 A A O H LEU VAL 5 16 1.59 5 A A HH21 O ARG GLY 1 2 1.46 5 A A O H ARG ARG 9 11 1.49 5 A A HH12 O ARG GLY 1 17 1.52 5 A A O H LEU VAL 5 16 1.59 6 A A O H TYR VAL 7 14 1.52 6 A A O HE CYS ARG 8 9 1.52 6 A A H O LEU VAL 5 16 1.55 6 A A O H LEU VAL 5 16 1.57 7 A A H3 O ARG GLY 1 17 1.45 7 A A O HH21 GLY ARG 2 18 1.47 8 A A HE O ARG GLY 1 2 1.42 8 A A HH21 O ARG GLY 1 3 1.46 8 A A H O ARG VAL 4 16 1.52 8 A A O H ARG ARG 9 11 1.53 8 A A O H TYR VAL 7 14 1.57 9 A A HE O ARG VAL 4 16 1.49 9 A A HE O ARG GLY 1 2 1.51 9 A A H O ARG PHE 9 12 1.51 9 A A O H LEU VAL 5 16 1.57 10 A A H1 O ARG GLY 1 17 1.42 10 A A O H ARG ARG 9 11 1.56 10 A A O H LEU VAL 5 16 1.59 11 A A HH12 O ARG ARG 1 4 1.45 11 A A HH11 O ARG GLY 1 2 1.49 11 A A O H ARG ARG 9 11 1.52 11 A A O H LEU VAL 5 16 1.58 12 A A H1 O ARG ARG 1 18 1.42 12 A A O HE GLY ARG 17 18 1.47 12 A A O H LEU VAL 5 16 1.58 12 A A H O ARG PHE 9 12 1.58 13 A A O H TYR VAL 7 14 1.45 13 A A O H ARG ARG 9 11 1.50 13 A A H O LEU VAL 5 16 1.55 14 A A H3 O ARG GLY 1 17 1.41 14 A A O H LEU VAL 5 16 1.59 14 A A H O LEU VAL 5 16 1.60 15 A A OH HH21 TYR ARG 7 9 1.47 15 A A O H TYR VAL 7 14 1.53 15 A A O H ARG ARG 9 11 1.54 15 A A H O ARG PHE 9 12 1.57 16 A A HH12 O ARG GLY 1 3 1.54 16 A A HH22 O ARG GLY 1 17 1.58 17 A A HH21 O ARG GLY 1 2 1.45 17 A A O H TYR VAL 7 14 1.58 17 A A O HN1 GLY NH2 3 19 1.58 18 A A H3 O ARG GLY 1 17 1.41 19 A A H1 OH ARG TYR 1 7 1.48 20 A A H1 O ARG ARG 1 4 1.43 20 A A O H ARG ARG 9 11 1.50 20 A A O H LEU VAL 5 16 1.53 1 A ARG 10 60.22 -58.90 1 A ARG 11 -146.39 14.74 2 A ARG 10 62.05 -65.23 2 A ARG 11 -148.11 20.81 3 A ARG 10 61.98 -62.01 3 A ARG 11 -147.60 18.08 4 A ARG 4 68.98 139.74 4 A ARG 10 59.42 -56.34 4 A ARG 11 -145.66 11.95 5 A ARG 10 59.34 -54.23 5 A ARG 11 -146.53 11.46 8 A ARG 10 59.51 -56.51 8 A ARG 11 -146.37 14.28 9 A ARG 4 68.65 137.44 9 A PHE 12 178.51 151.00 10 A ARG 10 60.10 -59.18 10 A ARG 11 -144.92 15.12 11 A ARG 4 66.49 150.23 11 A ARG 10 59.49 -56.46 11 A ARG 11 -144.41 11.26 12 A LEU 5 171.01 157.02 12 A PHE 12 163.77 174.18 13 A ARG 10 55.79 -56.21 14 A ARG 11 -145.62 37.04 15 A ARG 10 59.64 -56.88 15 A ARG 11 -146.85 14.51 16 A ARG 10 69.71 -62.90 16 A ARG 11 -170.30 22.08 16 A PHE 12 173.50 175.55 17 A LEU 5 179.88 168.19 17 A ARG 11 81.76 22.17 18 A PHE 12 157.67 -179.53 19 A LEU 5 151.14 -176.48 19 A ARG 11 91.53 13.17 20 A ARG 10 58.62 -54.85 20 A ARG 11 -143.39 10.40 model building X-PLOR 3.1 refinement X-PLOR 3.1 phasing X-PLOR 3.1 PROTEGRIN 1 (PG1) FROM PORCINE LEUKOCYTES, NMR, 20 STRUCTURES 1 Y N disulf 2.022 A CYS 6 A SG CYS 6 1_555 A CYS 15 A SG CYS 15 1_555 disulf 2.025 A CYS 8 A SG CYS 8 1_555 A CYS 13 A SG CYS 13 1_555 covale 1.303 both A ARG 18 A C ARG 18 1_555 A NH2 19 A N NH2 19 1_555 ANTIMICROBIAL PEPTIDE ANTIMICROBIAL PEPTIDE PG1_PIG UNP 1 1 P32194 METQRASLCLGRWSLWLLLLALVVPSASAQALSYREAVLRAVDRLNEQSSEANLYRLLELDQPPKADEDPGTPKPVSFTV KETVCPRPTRQPPELCDFKENGRVKQCVGTVTLDQIKDPLDITCNEVQGVRGGRLCYCRRRFCVCVGRG 131 148 1PG1 1 18 P32194 A 1 1 18 2 anti-parallel A ARG 4 A ARG 4 A ARG 9 A ARG 9 A PHE 12 A PHE 12 A GLY 17 A GLY 17 BINDING SITE FOR RESIDUE NH2 A 19 A NH2 19 Software 2 A GLY 17 A GLY 17 2 1_555 A ARG 18 A ARG 18 2 1_555 1 P 1